400 related articles for article (PubMed ID: 33389490)
41. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
42. Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.
Wu H; Zhou M; Lu G; Yang Z; Ji H; Hu Q
Biomed Pharmacother; 2017 Dec; 96():727-735. PubMed ID: 29045935
[TBL] [Abstract][Full Text] [Related]
43. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
Chen K; Zhang J; Zhang W; Zhang J; Yang J; Li K; He Y
Int J Biochem Cell Biol; 2013 May; 45(5):932-43. PubMed ID: 23434541
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
[TBL] [Abstract][Full Text] [Related]
45. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
[TBL] [Abstract][Full Text] [Related]
46. The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney.
Kim YG; Kim SM; Kim KP; Lee SH; Moon JY
Cells; 2019 Nov; 8(11):. PubMed ID: 31694192
[TBL] [Abstract][Full Text] [Related]
47. Uric acid regulates NLRP3/IL-1β signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K
Yin W; Zhou QL; OuYang SX; Chen Y; Gong YT; Liang YM
BMC Nephrol; 2019 Aug; 20(1):319. PubMed ID: 31412804
[TBL] [Abstract][Full Text] [Related]
48. Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway.
Yu Q; Zhang M; Qian L; Wen D; Wu G
Life Sci; 2019 May; 225():1-7. PubMed ID: 30935950
[TBL] [Abstract][Full Text] [Related]
49. Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome.
Chen F; Wei G; Xu J; Ma X; Wang Q
BMC Complement Altern Med; 2018 Jun; 18(1):192. PubMed ID: 29929501
[TBL] [Abstract][Full Text] [Related]
50. Dopamine D1 receptor agonist A68930 attenuates acute kidney injury by inhibiting NLRP3 inflammasome activation.
Cao JY; Zhou LT; Li ZL; Yang Y; Liu BC; Liu H
J Pharmacol Sci; 2020 Jul; 143(3):226-233. PubMed ID: 32446726
[TBL] [Abstract][Full Text] [Related]
51. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
Yang M; Zhao L
Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
[TBL] [Abstract][Full Text] [Related]
52. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
Lee HE; Yang G; Kim ND; Jeong S; Jung Y; Choi JY; Park HH; Lee JY
Sci Rep; 2016 Dec; 6():38622. PubMed ID: 27934918
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome.
Wang S; Fan J; Mei X; Luan J; Li Y; Zhang X; Chen W; Wang Y; Meng G; Ju D
Front Immunol; 2019; 10():2277. PubMed ID: 31616439
[TBL] [Abstract][Full Text] [Related]
54. NLRP3 inflammasome mediates contrast media-induced acute kidney injury by regulating cell apoptosis.
Shen J; Wang L; Jiang N; Mou S; Zhang M; Gu L; Shao X; Wang Q; Qi C; Li S; Wang W; Che X; Ni Z
Sci Rep; 2016 Oct; 6():34682. PubMed ID: 27721494
[TBL] [Abstract][Full Text] [Related]
55. Precipitation of Soluble Uric Acid Is Necessary for
Alberts BM; Barber JS; Sacre SM; Davies KA; Ghezzi P; Mullen LM
J Rheumatol; 2019 Sep; 46(9):1141-1150. PubMed ID: 30824640
[TBL] [Abstract][Full Text] [Related]
56. Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome‑mediated IL‑1β secretion via c‑Jun N‑terminal kinase activation and cell apoptosis during diabetic nephropathy.
Qiao Y; Tian X; Men L; Li S; Chen Y; Xue M; Hu Y; Zhou P; Long G; Shi Y; Liu R; Liu Y; Qi Z; Cui Y; Shen Y
Mol Med Rep; 2018 Aug; 18(2):1995-2008. PubMed ID: 29901140
[TBL] [Abstract][Full Text] [Related]
57. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
58. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway.
Chen ML; Zhu XH; Ran L; Lang HD; Yi L; Mi MT
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871042
[TBL] [Abstract][Full Text] [Related]
59. mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI.
Wen Y; Liu YR; Tang TT; Pan MM; Xu SC; Ma KL; Lv LL; Liu H; Liu BC
Int J Biochem Cell Biol; 2018 May; 98():43-53. PubMed ID: 29477360
[TBL] [Abstract][Full Text] [Related]
60. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
